Form 4: Fulgent Genetics CFO Paul Kim Acquires 100,000 Shares

Fulgent Genetics' CFO and Treasurer, Paul Kim, purchased 100,000 shares of the company's common stock at an average price of $15.9647 on March 5, 2025.

Summary

• On March 5, 2025, Paul Kim, the CFO and Treasurer of Fulgent Genetics, Inc., acquired 100,000 shares of common stock.
• The purchase was made at a weighted-average price of $15.9647 per share.
• The transactions ranged from $15.48 to $16.60 per share.
• Following the reported transaction, Kim directly owns 348,282 shares of Fulgent Genetics.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. It's a routine disclosure of insider buying, which can be seen as a vote of confidence, but it doesn't provide enough information to strongly influence sentiment.

Positives

• The CFO's purchase of a significant number of shares could be interpreted as a positive signal about his confidence in the company's future prospects.

Industry Context

Insider buying is often seen as a positive sign, suggesting that a company insider believes the stock is undervalued or that the company's prospects are strong. However, it's just one factor to consider when evaluating a stock.

Stakeholder Impact

• Shareholders may view the CFO's purchase as a positive signal.

Key Dates